Nearly two years into the pandemic-driven shift in how (and where) we work, employees have made it abundantly clear that they are seeking greater flexibility and autonomy from their employers – and they’re finally getting it. The ability to work some days at home and some days in the office (a hybrid model) or working[…]
Companies across the US are all too familiar with current hiring challenges: too many open roles and not enough qualified candidates. Fueled by “the Great Resignation” and a pandemic-era shift in priorities, along with a surge of new biotech companies and record IPOs, Regulatory Affairs job openings are at an all-time high. We are seeing[…]
As the post-pandemic job market continues to boom, much of the conversation dominating 2021 is around what experts are calling, “The Great Resignation”. This phrase was coined by associate management professor Anthony Klotz of Texas A&M University during a recent Bloomberg Businessweek interview; “’When there’s uncertainty, people tend to stay put, so there are pent-up[…]
Last October, we surveyed over 400 biotech and pharmaceutical professionals to learn if and when they were planning to return to their workplace in-person, as well as if and when they’d feel comfortable doing so. At that time, approximately 30% of respondents did not know when they’d return and 61% said they would not feel[…]
In November 2020 we asked companies about their plans for hiring and their biggest challenges in hiring Regulatory Affairs professionals for 2021. Overwhelmingly, companies told us that the biggest challenge they were facing was a lack of qualified candidates. In order to better understand how companies are combating their talent pool challenges, we conducted a[…]
Hiring in Regulatory Affairs has remained strong in biotech, pharma, and diagnostics this year despite the ongoing pandemic and economic uncertainty. In order to understand companies’ Regulatory hiring plans for 2021 and their Regulatory hiring challenges, Dennis Partners conducted an online survey of industry executives, decision-makers, HR professionals, and Regulatory hiring managers during the week[…]
The pandemic has dramatically changed the way people work within the biotech, pharmaceutical, and diagnostics industries. During the last six months, most non-laboratory employees have been working from home and have adjusted to “the new normal.” As many companies are now starting to explore options for returning to the office, we decided to conduct a[…]
